A New and Enantioselective Chromatographic Method for Linagliptin on Amylose Coated Chiral Stationary Phase
- 1 Dr. Reddy’s Laboratories Ltd., Active Pharmaceutical Ingredients, IPDO, Hyderabad, India
- 2 Department of Chemistry, J. N. T. University, Hyderabad, India
- 3 Department of Pediatrics, SUNY Stony Brook Medical Center, New York, USA
- 4 Dr. Reddy’s Laboratories Ltd., Active Pharmaceutical Ingredients, IPDO, Hyderabad, India
- 5 Dr. Reddy’s Laboratories Ltd., Active Pharmaceutical Ingredients, IPDO, Hyderabad, India
Abstract
A new and enantioselective liquid chromatographic method was developed for estimation of S-Linagliptin in Linagliptin (LINA) drug substances. The desired enantiomeric separation was achieved on Chiralpak AD-H (250*4.6 mm*5 μm) column with the mobile phase composition of ethanol, methanol and diethylamine in a ratio of 90:10:0.1 (v/v/v) with flow rate of 0.5 mL·min - 1 and column oven temperature 30°C and the eluted compounds were monitored at 225 nm. In the proposed chiral method, USP resolutions between both the enantiomers were more than 5.0. Limit of detection and Limit of quantitation of S-LINA was found to be 0.03 μg·mL -1 and 0.10 μg·mL -1 respectively. Linearity study was conducted from LOQ to 150% and correlation coefficient found to be 0.9997. Accuracy was within the range of 98.6% to 101.5%. To prove selectivity power of the method specificity study was conducted by subjecting drug substance to acid, base, hydrolysis, oxidation and photolysis and ensured the peak purity of analyte in degraded samples. Moreover, the method has been fully validated as per ICH guidelines. The proposed method is precise, accurate, linear, rugged, robust and suitable for accurate quantification of S-LINA in LINA drug substance.
- Nathan, D.M., Buse, J.B., Davidson, M.B., Ferrannini, E., Holman, R.R. and Sherwin, R. (2009) Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy: A Consensus Statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care, 32, 193-203. http://dx.doi.org/10.2337/dc08-9025
- Richter, B., Bandeira-Echtler, E., Bergerhoff, K. and Lerch, C. (2008) Emerging Role of Dipeptidyl Peptidase-4 Inhibitors in the Management of Type 2 Diabetes. Vascular Health and Risk Management, 4, 753-768.
- Scheen, A.J. (2011) Linagliptin for the Treatment of Type 2 Diabetes (Pharmacokinetic Evaluation). Expert Opinion on Drug Metabolism & Toxicology, 7, 1561-1576. http://dx.doi.org/10.1517/17425255.2011.628986
- Blech, S., Ludwig-Schwellinger, E., Graefe-Mody, E.U., Withopf, B. and Wagner, K. (2010) The Metabolism and Disposition of the Oral Dipeptidyl Peptidase-4 Inhibitor, Linagliptin, in Humans. Drug Metabolism and Disposition, 38, 667-678. http://dx.doi.org/10.1124/dmd.109.031476
- Perrin, S.P. and Pirkle, W.H. (1991) Commercially Available Brush-Type Chiral Selectors for Direct Resolution of Enantiomers. ACS Symposium Series, 471, 43-66. http://dx.doi.org/10.1021/bk-1991-0471.ch003
- Wainer, I.W., Alembik, M.C. and Smith, E. (1987) Resolution of Enantiomeric Amides on a Cellulose Tribenzoate Chiral Stationary Phase: Mobile Phase Modifier Effects on Retention and Stero-Selectivity. Journal of Chromatography A, 388, 65-74. http://dx.doi.org/10.1016/S0021-9673(01)94466-8
- Nguyen, L.A., He, H. and Pham-Huy, C. (2006) Chiral Drugs, an Overview. International Journal of Biomedical Science, 2, 85-100.
- ICH (1999) Topic Q6A Specifications: Test Procedures and Acceptance Criteria for New Drug Substances and New Drug Products. Chemical Substances.
- Gubitz, G. and Schmid, M.G. Methods in Molecular Biology. Chiral Separations Methods and Protocols, 243.
- Lammerhofer, M. and Lindner, W. Handbook of Analytical Separations, Recent Developments in Liquid Chromatographic Enantioseparation. Separation Methods in Drug Synthesis and Purification, 1, 337-437.
- Ye, Y.K., Lord, B.S., Yin, L. and Stringham, R.W. (2002) Enantioseparation of Amino Acids on a Polysaccharide-Based Chiral Stationary Phase. Journal of Chromatography A, 945, 147-159. http://dx.doi.org/10.1016/S0021-9673(01)01490-X